BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23585469)

  • 41. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
    Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
    Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Laminin 521 enhances self-renewal via STAT3 activation and promotes tumor progression in colorectal cancer.
    Qin Y; Shembrey C; Smith J; Paquet-Fifield S; Behrenbruch C; Beyit LM; Thomson BNJ; Heriot AG; Cao Y; Hollande F
    Cancer Lett; 2020 Apr; 476():161-169. PubMed ID: 32105676
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.
    Christensen LL; Holm A; Rantala J; Kallioniemi O; Rasmussen MH; Ostenfeld MS; Dagnaes-Hansen F; Øster B; Schepeler T; Tobiasen H; Thorsen K; Sieber OM; Gibbs P; Lamy P; Hansen TF; Jakobsen A; Riising EM; Helin K; Lubinski J; Hagemann-Madsen R; Laurberg S; Ørntoft TF; Andersen CL
    PLoS One; 2014; 9(6):e96767. PubMed ID: 24892549
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
    Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
    Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells.
    Fafilek B; Krausova M; Vojtechova M; Pospichalova V; Tumova L; Sloncova E; Huranova M; Stancikova J; Hlavata A; Svec J; Sedlacek R; Luksan O; Oliverius M; Voska L; Jirsa M; Paces J; Kolar M; Krivjanska M; Klimesova K; Tlaskalova-Hogenova H; Korinek V
    Gastroenterology; 2013 Feb; 144(2):381-391. PubMed ID: 23142137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomic profiling of a mouse model of acute intestinal Apc deletion leads to identification of potential novel biomarkers of human colorectal cancer (CRC).
    Hammoudi A; Song F; Reed KR; Jenkins RE; Meniel VS; Watson AJ; Pritchard DM; Clarke AR; Jenkins JR
    Biochem Biophys Res Commun; 2013 Oct; 440(3):364-70. PubMed ID: 23998936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LIMK2-1, a new isoform of human LIMK2, regulates actin cytoskeleton remodeling via a different signaling pathway than that of its two homologs, LIMK2a and LIMK2b.
    Vallée B; Cuberos H; Doudeau M; Godin F; Gosset D; Vourc'h P; Andres CR; Bénédetti H
    Biochem J; 2018 Dec; 475(23):3745-3761. PubMed ID: 30373762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Negative cross talk between LIMK2 and PTEN promotes castration resistant prostate cancer pathogenesis in cells and in vivo.
    Nikhil K; Kamra M; Raza A; Shah K
    Cancer Lett; 2021 Feb; 498():1-18. PubMed ID: 32931887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
    Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
    Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development.
    Piao MY; Cao HL; He NN; Xu MQ; Dong WX; Wang WQ; Wang BM; Zhou B
    Scand J Gastroenterol; 2016; 51(5):572-82. PubMed ID: 26691157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
    Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
    Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of LIM Kinase in the Male Urogenital System.
    Park J; Kim SW; Cho MC
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. c-Src drives intestinal regeneration and transformation.
    Cordero JB; Ridgway RA; Valeri N; Nixon C; Frame MC; Muller WJ; Vidal M; Sansom OJ
    EMBO J; 2014 Jul; 33(13):1474-91. PubMed ID: 24788409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
    Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
    Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
    [No Abstract]   [Full Text] [Related]  

  • 56. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism.
    Lu YX; Yuan L; Xue XL; Zhou M; Liu Y; Zhang C; Li JP; Zheng L; Hong M; Li XN
    Clin Cancer Res; 2014 May; 20(10):2631-42. PubMed ID: 24658157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-Producing Escherichia coli in Apc
    Lucas C; Salesse L; Hoang MHT; Bonnet M; Sauvanet P; Larabi A; Godfraind C; Gagnière J; Pezet D; Rosenstiel P; Barnich N; Bonnet R; Dalmasso G; Nguyen HTT
    Gastroenterology; 2020 Apr; 158(5):1373-1388. PubMed ID: 31917256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LIMK2 is required for membrane cytoskeleton reorganization of contracting airway smooth muscle.
    Li Y; Zhou Y; Wang P; Tao T; Wei L; Wang Y; Wang W; Zheng Y; Jiang Z; Qiu T; Zhao W; Sun J; Chen X; Zhang XN; Zhu MS
    J Genet Genomics; 2021 Jun; 48(6):452-462. PubMed ID: 34353741
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.
    Xu L; Li X; Cai M; Chen J; Li X; Wu WK; Kang W; Tong J; To KF; Guan XY; Sung JJ; Chan FK; Yu J
    Gut; 2016 Apr; 65(4):635-46. PubMed ID: 25947013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
    Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
    Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.